Product Images Tramadol Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Tramadol Hydrochloride NDC 55700-996 by Quality Care Products, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image description - 1
This is a description of a medication called Tramadol HCI ER Tablets USP 100 mg. The medication is packaged and distributed by 24@&'&/ édflfl p’ldm who can be contacted at 1-800-337-8603. It may be habit-forming, and the full prescribing information should be read before using. The tablets are made by Lupin Pharmaceuticals, Inc. in Baltimore, Maryland, and have a GTIN of 00355700996307. The medication must be stored at 77 degrees F, and the packaging includes a warning about its habit-forming potential. The medication is manufactured by Lupin Limited in India, and the packing also includes a lot and expiry date. Children should not have access to the medication.*
image-1 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 01
image-2 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 02
This is a graph showing the concentration of Tramadol in ng/mL over time in hours for two types of medication - Tramadol Hydrochloride Extended-Release Tablets (at a dose of 200 mg once a day) and Tramadol Hydrochloride Tablets (at a dose of 50 mg every 6 hours). The y-axis represents the concentration in ng/mL and the x-axis represents the time in hours. The graph shows that the extended-release tablets maintain a higher concentration of Tramadol in the blood for a longer time than the regular tablets.*
image-3 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 03
The text represents a graph of M1 concentration (ng/mL) over time (in hours) for two types of tramadol hydrochloride medication: extended-release tablets of 200 mg once a day and regular tablets of 50 mg taken six times a day. The graph shows a decreasing trend of M1 concentration over time for both medications.*
image-4 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 04
This appears to be a graph showing the percentage of patients who achieved various levels of response threshold for Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis. The graph shows the percentages for different dosage levels of the tablet - 100 mg, 200 mg, 300 mg, and 400 mg over a range of response thresholds (percent improvements from baseline). There is also a placebo line for comparison.*
image-5 - 7848ebcb 7a13 48a8 bbeb 7481d040c068 05
This is a chart that shows the percentage of patients achieving various levels of response threshold in a study of Tramadol Hydrochloride Extended-Release Tablets for arthritis pain intensity. The study is identified as Study 015. The chart compares the response rate of patients who took Tramadol Hydrochloride Extended-Release Tablets to those who took a placebo. The response threshold is measured by the percentage improvement in pain intensity from baseline.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.